In the evolving field of biochemical research, few compounds have garnered as much attention as the SS31 peptide elamipretide. As someone deeply interested in the mechanisms of cellular energy and mitochondrial health, I have spent significant time reviewing available data on this unique molecule. Often referred to simply as SS31 or elamipretide, this compound represents a fascinating shift in how we approach the study of cel Elamipretide (SS-31) shows robust mitochondrial-targeted bioactivity in both in vitro and in vivo models. In vitro, it selectively binds cardiolipin on the lular bioenergetics.
What is the SS31 Peptide Elamipretide?
At its core, elamipretide (also know The mitochondrial-targeted peptide, SS-31, improves n by development codes like MTP-131 or Bendavia) is a tetrapeptide—a short chain of amino acids—that has been specifically engineered to interact by MT Sweetwyne·2017·Cited by 116—Elamipretide (SS-31) is a mitochondria-targeted tetrapeptide thatselectively interacts with cardiolipin on the inner mitochondrial membrane. SS-31 enhances Read more with the inner mitochondrial membrane. It is widely recognized in scientific literature as a novel synthetic mitochondrial-targeted antioxidant. Unlike generic antioxidants that scavenge reactive oxygen species (ROS) throughout the cell, this mitochondrial antioxidant peptide is designed to localize specifically where the energy production occurs.
A key feature that defines this molecule is that it selectively interacts with cardiolipin on the inner mitochondrial membrane. Cardiolipin is a phospholipid essential for the structural integrity of the mitochondrial cristae and the optimal function of the electron transport chain. When cardiolipin is oxidized, mitochondrial function often declines; the presence of SS-31 helps stabilize these structures, which is why it is frequently described as a mitochondrially targeted small molecule.
Mechanisms and Research Focus
My interest in SS31 stems from its reported ability to influence bioenergetics. Preclinical studies showed benefit in cognitive impairment, muscle aging, atherosclerosis, osteoarthritis, diabetes, glaucoma, etc., but clinical trials in Read more Research indicates that elamipretide (SS-31) can improve mitochondrial function in various models. By binding to cardiolipin, it helps maintain the electron transport chain's efficiency Elamipretide / SS-31 Improves Muscle Function But Doesn' , which SS-31 (also known as Elamipretide®, Bendavia®, and leads to improved adenosine triphosphate (ATP) production.
Furthermore, studies have shown that elamipretide (SS31) rapidly improves physiological and mitochondrial function in aging. In aging tissues, mitochondria often become less efficient, leading to a decline in overall cellular capacity. This mitochondrially targeted antioxidant molecule is studied for its potential to reverse these age-related deficits, including those observed in cardiac tissue, where it rescues age-related functional deficits in the heart.
Exploring the Potential of SS-31
For those looking into the technical aspects of this substance, it is important to note that Elamipretide is an oligopeptide that has been the subject of extensive investigation. Some of the most compelling findings include:
* Improved ADP Sensitivity: Research suggests that elamipretide (SS-31) improves ADP sensitivity in aged mitochondria, allowing for better cellular respiration.
* Cardiac Function: In various preclinical models, advanced elamipretide protocols have demonstrated that it improves LV systolic function and helps normalize mitochondrial abnormalities in myocardial tissue.
* Mitochondrial Diseases: While elamipretide is an investigational drug being developed to treat mitochondrial diseases, it is perhaps best known for its potential application in conditions like Barth syndrome. In this context, it is a medication used for the treatment of Barth syndrome (or currently under study for such applications).
Observations on Research Use
When reviewing SS-31 (elamipretide) 50mg vials for research purposes, it is clear that the scientific community views this as a high-potential tool. Because it is a novel mitochondrial-targeted peptide, researchers often focus on its ability to reduce oxidative stress and optimize the internal environment of the mitochondria.
It is worth noting that while many peop Objective:Elamipretide (SS31) is a mitochondria-targeted peptide that has reported functions of stabilizing mitochondrial cristae structure and improving Read more le search for information regarding SS-31 peptide dosage or SS-31 peptide protocols, this substance remains strictly in the realm of laboratory investigation. It is not current by W Zhao·2019·Cited by 194—Thismitochondrial antioxidant peptidehas the ability to eliminate ROS and increase adenosine triphosphate (ATP) in mitochondria, thus maintaining the Read more ly available for personal use, and all discussions surrounding its efficacy—such as its potential to improve ADP sensitivity or stabilize cristae—should be interpreted through the lens of controlled scientific inquiry.
Conclusion
The study of SS31 peptide elamipretide continues to shed light on the importance of mitochondrial integrity in biological systems. Whether it is being utilized to investigate the structural stabilization of the inner mitochondrial membrane or its capacity to serve as a potent, targeted antioxidant, the compound remains a cornerstone of modern mitochondrial research. As we learn more about how it selectively interacts with cardiolipin, we gain a deeper appreciation for the Elamipretide (SS-31) Treatment Attenuates Age complex interplay between peptide chemistry and cellular longevity. For those of us tracking these developments, the progress of Elamipretide (SS-31) serves as a promising indicator of where the future of cellular research is heading.